BioLife Solutions Reportedly Attracts Takeover Interest from Repligen
BLFS sits 71% above its 52-week low of $17.86 on elevated volume (6.3× avg).
Summary
BioLife Solutions is reportedly drawing takeover interest, with Repligen Corp. cited as a potential suitor. This development follows strong Q1 2026 results and positive full-year guidance for 17-20% revenue growth. A potential acquisition could lead to a substantial premium for BLFS shareholders, especially given the stock's current proximity to its 52-week high.
At the time of this announcement, BLFS was trading at $30.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $17.86 to $29.81. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Binance News.